The deletion of TonB-dependent receptor genes is part of the genome reduction process that occurs during adaptation of Pseudomonas aeruginosa to the cystic fibrosis lung

Pathogens and Disease

Volumn 71, Issue 1, 2014, Pages 26-38

  Dingemans, Jozef ^a,b   Ye, Lumeng ^a   Hildebrand, Falk ^a,c   Tontodonati, Francesca ^a   Craggs, Michael ^a   Bilocq, Florence ^d   De Vos, Daniel ^d   Crabbé, Aurélie ^e   Van Houdt, Rob ^b   Malfroot, Anne ^a   Cornelis, Pierre ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b BELGIAN NUCLEAR RESEARCH CENTRE   (Belgium)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^d QUEEN ASTRID MILITARY HOSPITAL   (Belgium)

^e ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Cystic fibrosis; Deletions; Genomic islands; Pseudomonas aeruginosa; TonB dependent receptors; Type III secretion

Indexed keywords

ADAPTATION; ADOLESCENT; ADULT; ARTICLE; BACTERIAL GENOME; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CHILD; CLINICAL ARTICLE; CYSTIC FIBROSIS; GENE DELETION; GENOTYPE; HUMAN; LUNG INFECTION; NONHUMAN; POPULATION STRUCTURE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; TYPE III SECRETION SYSTEM; BACTERIAL GENE; BELGIUM; COMPLICATION; DEFICIENCY; DNA SEQUENCE; FEMALE; GENETICS; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; MOLECULAR GENETICS; YOUNG ADULT;

BACTERIAL PROTEIN; MEMBRANE PROTEIN; TONB PROTEIN, BACTERIA;

ADAPTATION, BIOLOGICAL; ADOLESCENT; ADULT; BACTERIAL PROTEINS; BELGIUM; CHILD; CYSTIC FIBROSIS; FEMALE; GENES, BACTERIAL; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEQUENCE ANALYSIS, DNA; SEQUENCE DELETION; YOUNG ADULT;

EID: 84901979121     PISSN: None     EISSN: 2049632X     Source Type: Journal    
DOI: 10.1111/2049-632X.12170     Document Type: Article

References (72)

1. Altschul SF, Gish W, Miller W, Myers EW & Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215: 403-410.
2. Anthony M, Rose B, Pegler MB et al. (2002) Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients. J Clin Microbiol 40: 2772-2778.
3. Banin E, Vasil ML & Greenberg EP (2005) Iron and Pseudomonas aeruginosa biofilm formation. P Natl Acad Sci USA 102: 11076-11081.
4. Baysse C, Meyer JM, Plesiat P, Geoffroy V, Michel-Briand Y & Cornelis P (1999) Uptake of pyocin S3 occurs through the outer membrane ferripyoverdine type II receptor of Pseudomonas aeruginosa. J Bacteriol 181: 3849-3851.
5. Bodilis J, Ghysels B, Osayande J et al. (2009) Distribution and evolution of ferripyoverdine receptors in Pseudomonas aeruginosa. Environ Microbiol 11: 2123-2135.
6. Boetzer M & Pirovano W (2012) Toward almost closed genomes with GapFiller. Genome Biol 13: R56.
7. Boetzer M, Henkel CV, Jansen HJ, Butler D & Pirovano W (2011) Scaffolding pre-assembled contigs using SSPACE. Bioinformatics 27: 578-579.
8. Cheng K, Smyth RL, Govan JR et al. (1996) Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 348: 639-6942.
9. Chung JC, Rzhepishevska O, Ramstedt M & Welch M (2013) Type III secretion system expression in oxygen-limited Pseudomonas aeruginosa cultures is stimulated by isocitrate lyase activity. Open Biol 3: 120131.
10. Corech R, Rao A, Laxova A et al. (2005) Early immune response to the components of the type III system of Pseudomonas aeruginosa in children with cystic fibrosis. J Clin Microbiol 43: 3956-3962.
11. Cornelis P & Bodilis J (2009) A survey of TonB-dependent receptors in fluorescent pseudomonads. Environ Microbiol Rep 1: 256-262.
12. Cornelis P & Dingemans J (2013) Pseudomonas aeruginosa adapts its iron uptake strategies in function of the type of infections. Front Cell Infect Microbiol 3: 75.
13. Cornelis P, Hohnadel D & Meyer JM (1989) Evidence for different pyoverdine-mediated iron uptake systems among Pseudomonas aeruginosa strains. Infect Immun 57: 3491-3497.
14. Cox CD, Rinehart KL Jr, Moore ML & Cook JC Jr (1981) Pyochelin: novel structure of an iron-chelating growth promoter for Pseudomonas aeruginosa. P Natl Acad Sci USA 78: 4256-4260.
15. Cramer N, Wiehlmann L, Ciofu O, Tamm S, Hoiby N & Tummler B (2012) Molecular epidemiology of chronic Pseudomonas aeruginosa airway infections in cystic fibrosis. PLoS ONE 7: e50731.
16. de Chial M, Ghysels B, Beatson SA et al. (2003) Identification of type II and type III pyoverdine receptors from Pseudomonas aeruginosa. Microbiology 149: 821-831.
17. De Vos D, De Chial M, Cochez C, Jansen S, Tummler B, Meyer JM & Cornelis P (2001) Study of pyoverdine type and production by Pseudomonas aeruginosa isolated from cystic fibrosis patients: prevalence of type II pyoverdine isolates and accumulation of pyoverdine-negative mutations. Arch Microbiol 175: 384-388.
18. Denayer S, Matthijs S & Cornelis P (2007) Pyocin S2 (Sa) kills Pseudomonas aeruginosa strains via the FpvA type I ferripyoverdine receptor. J Bacteriol 189: 7663-7668.
19. Deplano A, Denis O, Rodriguez-Villalobos H, De Ryck R, Struelens MJ & Hallin M (2011) Controlled performance evaluation of the DiversiLab repetitive-sequence-based genotyping system for typing multidrug-resistant health care-associated bacterial pathogens. J Clin Microbiol 49: 3616-3620.
20. Doleans-Jordheim A, Cournoyer B, Bergeron E et al. (2009) Reliability of Pseudomonas aeruginosa semi-automated rep-PCR genotyping in various epidemiological situations. Eur J Clin Microbiol Infect Dis 28: 1105-1111.
21. Dong YH, Zhang XF, Xu JL, Tan AT & Zhang LH (2005) VqsM, a novel AraC-type global regulator of quorum-sensing signalling and virulence in Pseudomonas aeruginosa. Mol Microbiol 58: 552-564.
22. Dumas Z, Ross-Gillespie A & Kümmerli R (2013) Switching between apparently redundant iron-uptake mechanisms benefits bacteria in changeable environments. Proc R Soc Lond B Biol Sci 280: 20131055.
23. Elfarash A, Wei Q & Cornelis P (2012) The soluble pyocins S2 and S4 from Pseudomonas aeruginosa bind to the same FpvAI receptor. Microbiologyopen 1: 268-275.
24. Elfarash A, Dingemans J, Ye L et al. (2014) Pore-forming pyocin S5 utilizes the FptA ferripyochelin receptor to kill Pseudomonas aeruginosa. Microbiology 160: 261-269.
25. Fluit AC, Terlingen AM, Andriessen L et al. (2010) Evaluation of the DiversiLab system for detection of hospital outbreaks of infections by different bacterial species. J Clin Microbiol 48: 3979-3989.
26. Fothergill JL, Walshaw MJ & Winstanley C (2012) Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections. Eur Respir J 40: 227-238.
27. Ghysels B, Dieu BT, Beatson SA, Pirnay JP, Ochsner UA, Vasil ML & Cornelis P (2004) FpvB, an alternative type I ferripyoverdine receptor of Pseudomonas aeruginosa. Microbiology 150: 1671-1680.
28. Grant JR & Stothard P (2008) The CGView server: a comparative genomics tool for circular genomes. Nucleic Acids Res 36: W181-W184.
29. Grissa I, Vergnaud G & Pourcel C (2007) CRISPRFinder: a web tool to identify clustered regularly interspaced short palindromic repeats. Nucleic Acids Res 35: W52-W57.
30. Hagins JM, Locy R & Silo-Suh L (2009) Isocitrate lyase supplies precursors for hydrogen cyanide production in a cystic fibrosis isolate of Pseudomonas aeruginosa. J Bacteriol 191: 6335-6339.
31. Hayden HS, Gillett W, Saenphimmachak C et al. (2008) Large-insert genome analysis technology detects structural variation in Pseudomonas aeruginosa clinical strains from cystic fibrosis patients. Genomics 91: 530-537.
32. Hu YH, Dang W & Sun L (2012) A TonB-dependent outer membrane receptor of Pseudomonas fluorescens: virulence and vaccine potential. Arch Microbiol 194: 795-802.
33. Hunter RC, Klepac-Ceraj V, Lorenzi MM, Grotzinger H, Martin TR & Newman DK (2012) Phenazine content in the cystic fibrosis respiratory tract negatively correlates with lung function and microbial complexity. Am J Respir Cell Mol Biol 47: 738-745.
34. Hunter RC, Asfour F, Dingemans J et al. (2013) Ferrous iron is a significant component of bioavailable iron in cystic fibrosis airways. MBio 4: e00513-e00557
35. Jelsbak L, Johansen HK, Frost AL et al. (2007) Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Infect Immun 75: 2214-2224.
36. Juhas M, van der Meer JR, Gaillard M, Harding RM, Hood DW & Crook DW (2009) Genomic islands: tools of bacterial horizontal gene transfer and evolution. FEMS Microbiol Rev 33: 376-393.
37. Konings AF, Martin LW, Sharples KJ, Roddam LF, Latham R, Reid DW & Lamont IL (2013) Pseudomonas aeruginosa uses multiple pathways to acquire iron during chronic infection in cystic fibrosis lungs. Infect Immun 81: 2697-2704.
38. Lamont IL, Konings AF & Reid DW (2009) Iron acquisition by Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis. Biometals 22: 53-60.
39. Langille MG & Brinkman FS (2009) IslandViewer: an integrated interface for computational identification and visualization of genomic islands. Bioinformatics 25: 664-665.
40. Lee DG, Urbach JM, Wu G et al. (2006) Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial. Genome Biol 7: R90.
41. Maatallah M, Bakhrouf A, Habeeb MA et al. (2013) Four genotyping schemes for phylogenetic analysis of Pseudomonas aeruginosa: comparison of their congruence with multi-locus sequence typing. PLoS ONE 8: e82069.
42. Masoud-Landgraf L, Badura A, Eber E et al. (2012) Molecular epidemiology of Pseudomonas aeruginosa in cystic fibrosis patients from Southeast Austria. Wien Klin Wochenschr 124: 262-265.
43. Meyer JM (2000) Pyoverdines: pigments, siderophores and potential taxonomic markers of fluorescent Pseudomonas species. Arch Microbiol 174: 135-142.
44. Meyer JM, Stintzi A, De Vos D, Cornelis P, Tappe R, Taraz K & Budzikiewicz H (1997) Use of siderophores to type pseudomonads: the three Pseudomonas aeruginosa pyoverdine systems. Microbiology 143: 35-43.
45. Meyer F, Paarmann D, D'Souza M et al. (2008) The metagenomics RAST server - a public resource for the automatic phylogenetic and functional analysis of metagenomes. BMC Bioinformatics 9: 386.
46. Michel-Briand Y & Baysse C (2002) The pyocins of Pseudomonas aeruginosa. Biochimie 84: 499-510.
47. Moss J, Ehrmantraut ME, Banwart BD, Frank DW & Barbieri JT (2001) Sera from adult patients with cystic fibrosis contain antibodies to Pseudomonas aeruginosa type III apparatus. Infect Immun 69: 1185-1188.
48. Mossialos D, Ochsner U, Baysse C et al. (2002) Identification of new, conserved, non-ribosomal peptide synthetases from fluorescent pseudomonads involved in the biosynthesis of the siderophore pyoverdine. Mol Microbiol 45: 1673-1685.
49. Pessi G & Haas D (2000) Transcriptional control of the hydrogen cyanide biosynthetic genes hcnABC by the anaerobic regulator ANR and the quorum-sensing regulators LasR and RhlR in Pseudomonas aeruginosa. J Bacteriol 182: 6940-6949.
50. Pessi G & Haas D (2001) Dual control of hydrogen cyanide biosynthesis by the global activator GacA in Pseudomonas aeruginosa PAO1. FEMS Microbiol Lett 200: 73-78.
51. Pirnay JP, Matthijs S, Colak H et al. (2005) Global Pseudomonas aeruginosa biodiversity as reflected in a Belgian river. Environ Microbiol 7: 969-980.
52. Pirnay JP, Bilocq F, Pot B et al. (2009) Pseudomonas aeruginosa population structure revisited. PLoS ONE 4: e7740.
53. Ratkai C, Peixe LV, Grosso F et al. (2010) Successful application of the DiversiLab repetitive-sequence-based PCR typing system for confirmation of the circulation of a multiresistant Pseudomonas aeruginosa clone in different hospital wards. Diagn Microbiol Infect Dis 67: 202-206.
54. Rau MH, Marvig RL, Ehrlich GD, Molin S & Jelsbak L (2012) Deletion and acquisition of genomic content during early stage adaptation of Pseudomonas aeruginosa to a human host environment. Environ Microbiol 14: 2200-2211.
55. Ravel J & Cornelis P (2003) Genomics of pyoverdine-mediated iron uptake in pseudomonads. Trends Microbiol 11: 195-200.
56. Reen FJ, Haynes JM, Mooij MJ & O'Gara F (2013) A non-classical LysR-type transcriptional regulator PA2206 is required for an effective oxidative stress response in Pseudomonas aeruginosa. PLoS ONE 8: e54479.
57. Roy PH, Tetu SG, Larouche A et al. (2010) Complete genome sequence of the multiresistant taxonomic outlier Pseudomonas aeruginosa PA7. PLoS ONE 5: e8842.
58. Rozen S & Skaletsky HJ (1998) Primer 3. Code available at http://www.genome.wi.mit.edu/genome_software/other/primer3.html.
59. Scott FW & Pitt TL (2004) Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales. J Med Microbiol 53: 609-615.
60. Smith EE, Sims EH, Spencer DH, Kaul R & Olson MV (2005) Evidence for diversifying selection at the pyoverdine locus of Pseudomonas aeruginosa. J Bacteriol 187: 2138-2147.
61. Stover CK, Pham XQ, Erwin AL et al. (2000) Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406: 959-964.
62. Tummler B & Cornelis P (2005) Pyoverdine receptor: a case of positive Darwinian selection in Pseudomonas aeruginosa. J Bacteriol 187: 3289-3292.
63. Visca P, Imperi F & Lamont IL (2007) Pyoverdine siderophores: from biogenesis to biosignificance. Trends Microbiol 15: 22-30.
64. Wang Y, Wilks JC, Danhorn T, Ramos I, Croal L & Newman DK (2011) Phenazine-1-carboxylic acid promotes bacterial biofilm development via ferrous iron acquisition. J Bacteriol 193: 3606-3617.
65. Wiens JR, Vasil AI, Schurr MJ & Vasil ML (2014) Iron-regulated expression of alginate production, mucoid phenotype, and biofilm formation by Pseudomonas aeruginosa. MBio 4: e00513-e00557.
66. Winsor GL, Lam DK, Fleming L et al. (2011) Pseudomonas genome database: improved comparative analysis and population genomics capability for Pseudomonas genomes. Nucleic Acids Res 39: D596-D600.
67. Winstanley C, Langille MG, Fothergill JL et al. (2009) Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa. Genome Res 19: 12-23.
68. Worlitzsch D, Tarran R, Ulrich M et al. (2002) Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 109: 317-325.
69. Yang L, Jelsbak L & Molin S (2011a) Microbial ecology and adaptation in cystic fibrosis airways. Environ Microbiol 13: 1682-1689.
70. Yang L, Jelsbak L, Marvig RL et al. (2011b) Evolutionary dynamics of bacteria in a human host environment. P Natl Acad Sci USA 108: 7481-7486.
71. Zerbino DR & Birney E (2008) Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res 18: 821-829.
72. Zhou Y, Liang Y, Lynch KH, Dennis JJ & Wishart DS (2011) PHAST: a fast phage search tool. Nucleic Acids Res 39: W347-W352.